Cargando…
Metformin treatment of diverse Caenorhabditis species reveals the importance of genetic background in longevity and healthspan extension outcomes
Metformin, the most commonly prescribed anti‐diabetes medication, has multiple reported health benefits, including lowering the risks of cardiovascular disease and cancer, improving cognitive function with age, extending survival in diabetic patients, and, in several animal models, promoting youthfu...
Autores principales: | Onken, Brian, Sedore, Christine A., Coleman‐Hulbert, Anna L., Hall, David, Johnson, Erik, Jones, Eleanor Grace, Banse, Stephen A., Huynh, Phu, Guo, Suzhen, Xue, Jian, Chen, Esteban, Harinath, Girish, Foulger, Anna C., Chao, Elizabeth A., Hope, June, Bhaumik, Dipa, Plummer, Todd, Inman, Delaney, Morshead, Mackenzie, Guo, Max, Lithgow, Gordon J., Phillips, Patrick C., Driscoll, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761014/ https://www.ncbi.nlm.nih.gov/pubmed/34837316 http://dx.doi.org/10.1111/acel.13488 |
Ejemplares similares
-
ROBUST LONGEVITY EFFECTS OF NOVEL COMPOUNDS TESTED BY THE CAENORHABDITIS INTERVENTION TESTING PROGRAM
por: Driscoll, Monica, et al.
Publicado: (2022) -
Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects
por: Lucanic, Mark, et al.
Publicado: (2017) -
Translating longevity research into healthspan
por: Lithgow, Gordon J, et al.
Publicado: (2012) -
Automated lifespan determination across Caenorhabditis strains and species reveals assay-specific effects of chemical interventions
por: Banse, Stephen A., et al.
Publicado: (2019) -
Caenorhabditis Intervention Testing Program: the tyrosine kinase inhibitor imatinib mesylate does not extend lifespan in nematodes
por: Coleman-Hulbert, Anna L., et al.
Publicado: (2019)